Beruflich Dokumente
Kultur Dokumente
DOI: 10.1111/j.1468-3083.2011.04397.x
ORIGINAL ARTICLE
Department of Microbiology, Faculty of Medicine, Resident, Suleyman Demirel University, Isparta, Turkey
*Correspondence: P.Y. Bas ak. E-mail: pinarbasak@hotmail.com
Abstract
Background Although there are several studies about the alteration in skin flora, limited number of reports about
changes in the microbial contents and their resistance profile of other body sites in patients treated with isotretinoin
for acne vulgaris.
Objectives The aim of this study was to investigate the effects of systemic isotretinoin and antibiotic therapy on
the microbial floras of oropharynx, nose and feces in acne patients.
Methods Treatment groups of isotretinoin and antibiotics consisting of 20 and 15 patients, respectively were
included. Microbiological culture samples were taken at baseline and once a month during 46 months of treatment
period.
Results Difference in microbial flora throughout the treatment period was detected at least among one of all
culture samples of 15 (75%) and 5 (33%) patients in isotretinoin and antibiotic groups. There was statistically
significant difference between two groups in means of alteration of the microbial flora (P 0.013). The difference
was definitely observed among nasal cultures (65%) in isotretinoin group and fecal cultures (20%) in the other.
Staphylococcus aureus colonization was prominent in the microbial floras of nose and oropharynx and 2 of 14 nasal
isolates were detected to be methicilline resistant while Escherichia coli with extended spectrum beta lactamase
activity was detected in fecal floras of patients in isotretinoin group.
Conclusions Systemic isotretinoin and antibiotic treatments in acne patients precisely caused variations in the
microbial floras of several sites of the body, while isotretinoin was commonly more responsible than antibiotics.
Knowing that alterations in the microbial colonization of the flora regions may preceede infectious disease and
bacterial resistance, treatment options and follow-up procedures in acne vulgaris should be carefully determined to
reduce the risk of destruction of the microbial flora.
Received: 3 October 2011; Accepted: 23 November 2011
Conflict of interest
None declared.
Introduction
Oral isotretinoin and antibiotics namely tetracyclines and macrolides are considered as successful therapeutic choices for acne vulgaris. However, there are remarkable reports emphasizing the
presence of alteration in the cutaneous microbial flora during
treatment with these agents. An interesting point is that each of
these treatment modalities might increase the possibility of causing
a resistant phenotype permanent which is an undesirable consequence in this type of benign condition.1,2 Changes in the antibiotic resistance profiles and quantitative levels of Propionibacterium
acnes were mainly investigated in previous studies.35 Decremental
numbers of P. acnes and Gram negative bacilli were detected
although Staphylococcus aureus colonization was reported to be
increased.6 In addition, skin colonization with resistant propionibacteria and secondary folliculitis most commonly associated with
Gram negative enteric bacteria have also been suggested for
treatment failure among these patients.7,8
Normal oropharyngeal flora includes anaerobic and aerobic
species like Peptostreptococcus and viridans streptococci which are
rarely considered as pathogenic.9 Staphylococcus species, importantly S. aureus, may also be part of the normal oropharyngeal
flora, but S. aureus is more likely to be pathogenic.10 Nevertheless,
the main site of S. aureus colonization is regarded as anterior nares
and this reservoir is found to be responsible for the facial skin
colonization and consequently furonculosis and folliculitis of the
several skin sites.5,6,11 Moreover, gastrointestinal tracts of colonized
333
S. aureus strains were determined by the KirbyBauer disc diffusion method with cefoxitin (30 lg) discs following the criteria of
the Clinical and Laboratory Standards Institute.15
Faeces samples were directly inoculated on to blood agar and
eosin methylene blue agar, and on to xylose lysine deoxycholate
and Salmonella-Shigella agar after enrichment in Selenit F
buyyon. For the screening of ESBL-producing Enterobactericeae,
samples were also inoculated on to the screen agar plates with
two divisions, one half of which were consisted of Drigalski
agar with 1.5 lg mL cefotaxime (DR-CTX) and the other half
consisting of MacConkey agar with 2 lg mL ceftazidime
(MC-CAZ). All the plates were incubated at 37 C and checked
for growth after 2448 h. Growth on the MC-CAZ and or the
DR-CTX half-dish together with the strains ability to ferment
lactose was taken to signify a presumptive ESBL organism. All
the visible colonies on screen agar plates were identified to species level by using conventional methods like Gram staining,
catalase and oxidase tests and by using BBL Crystal Identification Systems (Enteric Nonfermenter ID Kit, Becton Dickinson
and Company, MD, USA) and evaluated for ESBL production
using phenotypical methods according to the recommendations
of CLSI.15
Presence of any difference in the microbial floras throughout
the treatment period was evaluated and the two treatment groups
were compared statistically for the frequency of this difference.
Statistical evaluation
Results
Twenty-four female patients and 11 male patients with acne vulgaris between the ages of 15 and 24 (20.14 2.02) were enrolled in
the study. The duration of acne ranged from 4 months to 10 years
(55.37 27.96 months). The patients had mild (5, 14.3%), moderate (25, 71.4%) or severe (5, 14.3%) disease and acne lesions
were localized only on the face (12, 34.3%), only on the trunk (1,
2.9%) and both on face and trunk (22, 62.9%). The two treatment
Systemic
antibiotic
(n = 15)
25
6.6
0.207*
13
65
6.6
0.001
20
20
1.00*
Bas ak et al.
334
Table 2 Number and percentage of patients colonized with S. aureus in the oropharyngeal and nasal cultures and ESBL positive
E. coli in the faecal floras before and after the treatments
Isotretinoin (n = 20)
After
Before
Before
Oropharynx
15
40
0.063
%
0
After
0
%
0
Nose
15
14
70
0.001*
1.00
Faeces
20
0.125
20
33.3
0.625
1.00
*McNemar test.
Discussion
This study demonstrates not only increased alteration rates in the
microbial contents of nasal and oropharyngeal floras but also
emergence of resistant strains especially in faecal flora due to isotretinoin treatment for acne. This confirms the findings of previous reports although most of them were about the alteration in
the skin flora concerning P. acnes.4,5,16,17
Leyden and James11 and Williams et al.18 suggested that the
appearance of furonculosis and folliculitis was related with the
increase in nasal S. aureus colonization in acne patients under isotretinoin treatment. It was also reported that S. aureus colonization in the anterior nares was increased from 2.5% to 70% after
5 months of isotretinoin therapy for acne conglobata.5 Similarly,
S. aureus was recovered from the anterior nares of 64% of patients
treated during a 5-month course of isotretinoin.11 Supporting the
findings of these previous studies, significant increase in S. aureus
colonization from 15% to 70% after isotretinoin treatment demonstrated both the important effect of isotretinoin in the alteration
of nasal flora and its significant difference from the antibiotic
group, in the present investigation. Topically applied antibiotics to
anterior nares during isotretinoin treatment was reported to
diminish S. aureus colonization11,18 and prevent clinical infection
after therapy.11 Therefore, topical antibiotics to anterior nares
might be suggested in patients receiving isotretinoin for acne
although their routine application was reported to be not justifiable.18
In this study, S. aureus colonization in oropharynx was found
to be 40% due to isotretinoin whereas there was no difference in
335
Conclusion
Systemic isotretinoin and antibiotic treatments in acne patients
precisely caused variations in the microbial floras of several sites of
the body, although isotretinoin was commonly more responsible
than antibiotics. Once a patients body site was colonized with
resistant bacteria, it may become stabilized and may persist for a
long time regardless of the treatment procedures.13 Knowing that
alterations in the microbial colonization of the flora regions may
precede an infectious disease and bacterial resistance,11,18,24 the
findings of our study present considerable background to propose
that alteration of these floras due to isotretinoin treatment for
acne vulgaris can provide a source of resistant bacterial infections.
For this reason, treatment options and follow-up procedures in
acne vulgaris should be carefully determined to reduce the risk of
destruction of the microbial flora.
Bas ak et al.
336
References
1 Mills O Jr, Thornsberry C, Cardin CW, Smiles KA, Leyden JJ.
Bacterial resistance and therapeutic outcome following three months of
topical acne therapy with 2% erythromycin gel versus its vehicle. Acta
Derm Venereol 2002; 82: 260265.
2 Espersen F. Resistance to antibiotics used in dermatological practice.
Br J Dermatol 1998; 139: 48.
3 Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman
AM. Propionibacterium acnes resistance to antibiotics in acne
patients. J Am Acad Dermatol 1983; 8: 4145.
4 Weissmann A, Wagner A, Plewig G. Reduction of bacterial skin flora
during oral treatment of severe acne with 13-cis retinoic acid. Arch
Dermatol Res 1981; 270: 179183.
5 Leyden JJ, McGinley KJ, Foglia AN. Qualitative and quantitative
changes in cutaneous bacteria associated with systemic isotretinoin
therapy for acne conglobata. J Invest Dermatol 1986; 86: 390393.
6 James WD, Leyden JJ. Treatment of gram-negative folliculitis with
isotretinoin: positive clinical and microbiologic response. J Am Acad
Dermatol 1985; 12(2 Pt 1): 319324.
7 Eady EA, Cove JH, Blake J et al. Recalcitrant acne vulgaris. Clinical,
biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988; 118: 415423.
8 Oprica C, Emtestam L, Hagstromer L, Nord CE. Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris. Acta
Derm Venereol 2007; 87: 246254.
9 Mobbs KJ, van Saene HKF, Sunderland D, Davies PDO. Oropharyngeal
gram negative bacillary carriage. Chest 1999; 115: 15701575.
10 Sveinbjornsdottir S, Gudmundsson S, Briem H. Oropharyngeal colonization in the elderly. Eur J Clin Microbiol Infect Dis 1991; 10: 959963.
11 Leyden JJ, James WD. Staphylococcus aureus infection as a complication
of izotretinoin therapy. Arch Dermatol 1987; 123: 606608.
12 Lucet JC, Chevret S, Decre D et al. Outbreak of multiply resistant
Enterobacteriaceae in an intensive care unit: epidemiology and risk
factors for acquisition. Clin Infect Dis 1996; 22: 430436.
13 Pena C, Pujol M, Ardanuy C et al. Epidemiology and successful control
of a large outbreak due to Klebsiella pneumoniae producing extendedspectrum beta-lactamases. Antimicrob Agents Chemother 1998; 42: 5358.
14 Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading
systems and proposal of a novel system. Int J Dermatol 1997; 36:
416418.
15 Wayne PA. Clinical and Laboratory Standards Institute. Performance
standards for antimicrobial susceptibility testing. 2009; M100-S19:
19th informational supplement.
16 King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of
the effects of 13-cis-retinoic acid on acne, sebum excretion rate and
microbial population. Br J Dermatol 1982; 107: 583590.
This document is a scanned copy of a printed document. No warranty is given about the accuracy of the copy.
Users should refer to the original published version of the material.